Dr. Wu, Jia-Ru
E-mail:u8931246@yahoo.com.tw
Ext03-8565301#2434(Tzu Chi University)
Tzu Chi University, Taiwan. Ph.D.  

Expertise

 

(Molecular and Cellular Biology)(Cancer Biology)

(Biological Science and Technology)

(Laboratory Medicine and Biotechnology)

(Purification and Isolation of Chinese Herbal Medicine)

(Screening of Active Ingredients of Herbal Medicine)

 

Interest

 (Oncology) (Molecular and Cellular Biology) (Screening and Identification of Active Ingredients of Chinese Herbal Medicine)

 

Publication (in five years)

1.

Jia-Ru Wu, Ren-In You, Chi-Tan Hu, Chuan-Chu Cheng, Rudy Rudy, Wen-Sheng wu (2019, Jun). Hydrogen peroxide inducible clone-5 sustains NADPH oxidase-dependent reactive oxygen species-c-jun N-terminal kinase signaling in hepatocellular carcinoma. Oncogenesis, [Paper #ONCSIS-18-0406R]

2.

Chang HY, Wu JR, Gao WY, Lin HR, Chen PY, Chen CI, Wu MJ, Yen JH (2019, Jan). The Cholesterol-Modulating Effect of Methanol Extract of Pigeon Pea (Cajanus cajan (L.) Millsp.) Leaves on Regulating LDLR and PCSK9 Expression in HepG2 Cells.. Molecules, 24(3), doi: 10.3390/molecules24030493.

3. You RI, Wu WS, Cheng CC, Wu JR, Pan SM, Chen CW, Hu CT (2018, Dec). Involvement of N-glycan in Multiple Receptor Tyrosine Kinases Targeted by Ling-Zhi-8 for Suppressing HCC413 Tumor Progression.. Cancers (Basel), 11(1), doi: 10.3390/cancers11010009.
4.

Hu, C.T., Wu, J.R., Cheng, C.C., Wu, W.S. (2017, May). The Therapeutic Targeting of HGF/c-Met Signaling in Hepatocellular Carcinoma: Alternative Approaches. Cancers (Basel), 9(6).

5.

Jia-Ru Wu, Chi-Tan Hu, Ren-In You, Siou-Mei Pan, Chuan-Chu Cheng, Ming-Che Lee, Chao-Chuan Wu, Yao-Jen Chang, Shu-Chuan Lin, Chang–Shan Chen, Teng-Yi Lin, Wen-Sheng Wu (2015, Aug). Hydrogen peroxide inducible clone-5 mediates reactive oxygen species signaling for hepatocellular carcinoma progression. Oncotarget.

6.

Hu CT, Cheng CC, Wu JR, Pan SM, Wu WS (2015, Jul). PKCε-mediated c-Met endosomal processing directs fluctuant c-Met-JNK-paxillin signaling for tumor progression of HepG2. Cellular Signalling, 27(7), 1544-55.

7. Wu JR, Hu CT, You RI, Ma PL, Pan SM, Lee MC, Wu WS (2015, Jan). Preclinical trials for prevention of tumor progression of hepatocellular carcinoma by LZ-8 targeting c-Met dependent and independent pathways. PLoS One, 10(1), e011449

                                               

 

您目前位置:Home News and Events 吳家如博士